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Recent studies in humans and in genetic mouse
models have identified Slit- and NTRK-like family
(Slitrks) as candidate genes for neuropsychiatric dis-
orders. All Slitrk isotypes are highly expressed in the
CNS,where theymediateneurite outgrowth, synapto-
genesis, and neuronal survival. However, themolecu-
lar mechanisms underlying these functions are not
known. Here, we report that Slitrk5 modulates brain-
derived neurotrophic factor (BDNF)-dependent bio-
logical responses through direct interaction with
TrkB receptors. Under basal conditions, Slitrk5 inter-
acts primarily with a transsynaptic binding partner,
protein tyrosine phosphatase d (PTPd); however,
upon BDNF stimulation, Slitrk5 shifts to cis-interac-
tions with TrkB. In the absence of Slitrk5, TrkB has a
reduced rate of ligand-dependent recycling and
altered responsiveness to BDNF treatment. Struc-
tured illumination microscopy revealed that Slitrk5
mediates optimal targeting of TrkB receptors to
Rab11-positive recyclingendosomes through recruit-
ment of a Rab11 effector protein, Rab11-FIP3. Thus,
Slitrk5 acts as a TrkB co-receptor that mediates its
BDNF-dependent trafficking and signaling.690 Developmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier IINTRODUCTIONMembers of the Slit- and NTRK-like family (Slitrks) are type 1
transmembraneproteins that localize to and function atCNSsyn-
apses where they mediate synapse formation through transsy-
naptic interactions of their ectodomains with presynaptic binding
partners (Linhoff et al., 2009; Takahashi et al., 2012; Yim et al.,
2013). Their cytoplasmic tails, larger than those of other well-
studied synaptic adhesion molecules (SAMs), e.g., neurexins,
neuroligins, leucine-rich repeat transmembranes (LRRTMs), syn-
aptic cell adhesion molecules (SynCAMs), N-cadherins, and L1
adhesion molecules (Aruga and Mikoshiba, 2003; Proenca
et al., 2011), suggest functional interactionswith othermolecules.
Slitrks have structural and functional similarity to tropomyosin
receptor kinase (Trk) neurotrophin receptors. They contain N-ter-
minal leucine-rich repeat (LRR) domains and intracellular tyro-
sine-based motifs similar to those found in TrkA, TrkB, and
TrkC. Furthermore, Slitrks mediate biological functions similar
to Trk receptors, including neurite outgrowth and dendritic elab-
oration, synapse formation, and neuronal survival (Aruga andMi-
koshiba, 2003; Ko, 2012; Proenca et al., 2011; Yim et al., 2013). It
is well established that Trk receptors mediate this broad range of
functions through their selective binding to three major ligands:
nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF), and neurotrophin-3 (NT-3) (Chao, 2003).
A key question is how such a limited repertoire of neurotro-
phins and Trk receptors mediates such a diverse array ofnc.
biological actions. In the peripheral nervous system (PNS), the
basic strategy to generate signaling diversity has been eluci-
dated. In sensory and sympathetic neurons, Trk receptors are
expressed at high levels and form combinatorial complexes
with their co-receptor p75NTR at the plasma membrane. These
interactions increase their affinity and selectivity for specific neu-
rotrophins (Benedetti et al., 1993; Hempstead et al., 1991; Kuru-
villa et al., 2004; Lee et al., 1994). In contrast, in the adult CNS,
the strategy underlying signaling diversity remains essentially
unknown. Whereas TrkB and TrkC receptors are expressed
at high levels in the CNS, p75NTR has a limited distribution,
restricted primarily to the basal forebrain (Huang and Reichardt,
2003; Lee et al., 2001). Hence, it is likely that regulation of Trk
function in the CNS involves alternative molecules.
Slitrks are excellent candidates to perform such regulatory
functions. Of the six Slitrk family members expressed in the
CNS (Aruga and Mikoshiba, 2003; Shmelkov et al., 2010), Slitrk5
provides the more compelling links with the neurotrophin sys-
tem. Slitrk5/ mice display altered anatomical and neuronal
morphological phenotypes in the striatum similar to those
observed in the striatum of mice with genetic deficiencies in
BDNF or TrkB (Emx-BDNF, Tau-BDNF, Dlx5/6-TrkB, and Bf1-
BDNF knockout [KO] mice) (Baquet et al., 2004; Baydyuk et al.,
2011; Li et al., 2012; Rauskolb et al., 2010; Shmelkov et al.,
2010). This raises the intriguing question of whether in the CNS
Slitrk5 functions through direct interaction and modulation of
the neurotrophin system. Here, we present mechanistic evi-
dence demonstrating that Slitrk5 acts as a co-receptor of TrkB
that modulates its postendocytic recycling to facilitate BDNF-
dependent signaling responses. Our study identifies a key regu-
lator of the diverse array of BDNF functions in the CNS.
RESULTS
Slitrk5 Interacts with TrkB Receptors
To determine whether Slitrk5 and TrkB receptors are physically
associated, we carried out co-immunoprecipitation studies in
cell lines and primary neurons. Studies using HEK293T cells
transfected with FLAG-tagged TrkB and wild-type (WT) Slitrk5
plasmids (Figure 1A) or HEK293 cells stably expressing TrkB
(HEK293-TrkB) transfected with GFP-tagged Slitrk5 (Figure 1B)
clearly demonstrated that the two proteins interact. Furthermore,
co-immunoprecipitation studies in brain lysates using anti-TrkB
antibodies or anti-Slitrk5 antibodies demonstrated that endoge-
nous Slitrk5 and TrkB interact in neurons (Figures 1C and S1E).
This interaction is specific, as it was not observed for other Slitrk
members (Slitrk1–3) (Figure 1D), or for the other major CNS neu-
rotrophin receptor, TrkC, in primary cultured neurons (Figures 1E
and S1E). To map the Slitrk5 and TrkB domains that mediate
their interaction, we utilized a chimera-based approach. The
extracellular domain of Slitrk5 encodes two LRR domains (Fig-
ure 1F). LRR domains often mediate protein-protein interactions
(Gay et al., 1991; Mandai et al., 2009). We swapped the extra-
cellular domains of Slitrk5 with the corresponding domains
of another Slitrk (Slitrk1) (Figure 1F). After transfection of
HEK293-TrkB cells with the chimeric Slitrk5 constructs, their
interaction with TrkB was assessed by co-immunoprecipitation
and immunoblot analyses. These studies demonstrated that
the interaction of Slitrk5 with TrkB was mediated by its firstDevelLRR (LRR1) domain (Figure 1F). Complementary studies with
chimeras between TrkB and TrkC demonstrated that binding
of TrkB with Slitrk5 is mediated by its single LRR domain (Fig-
ure 1G). Taken together, these studies demonstrate that Slitrk5
and TrkB interact specifically via their extracellular LRRdomains.
Next, we carried out co-immunoprecipitation experiments to
examine whether the interaction between Slitrk5 and TrkB is
modulated by BDNF-dependent TrkB activation. These experi-
ments showed that, compared to the control condition (10%
fetal bovine serum [FBS]; Figures 1A and 1B), serum starvation
(0% FBS) significantly reduced the basal interaction between
FLAG-tagged Slitrk5 and TrkB (Figure 1H). In contrast, upon
BDNF stimulation, the interaction between Slitrk5 and TrkB
was significantly increased, and was blocked by pretreatment
with K252a, an inhibitor of Trk kinases (Figure 1H). These studies
suggest that Slitrk5 optimally interacts with a TrkB receptor com-
plex that is activated by BDNF.
We next considered whether Slitrk5 and TrkB receptors co-
localized within neurons. To test this hypothesis, we examined
the subcellular localization of endogenous Slitrk5 and TrkB re-
ceptors in cultured striatal neurons using structured illumination
microscopy (SIM), a form of high-resolution microscopy that
uses a high-frequency striped pattern of light to illuminate the
sample in multiple angles to enhance image resolution up to
85 nm (Gustafsson, 2000). In untreated striatal neurons, TrkB
and Slitrk5 localized separately in dendrites, visualized with
microtubule-associated protein 2 (MAP2) staining (Figure 1I,
left panels; quantified in Figure 1J). In contrast, after BDNF treat-
ment, TrkB receptors significantly co-localized with Slitrk5 in
enlarged punctate structures, presumably reflecting its presence
in endosomes (Figure 1I, right panels; quantified in Figures 1J
and S1F). The co-localization of TrkB and Slitrk5 was visualized
with co-localization highlighter (ImageJ, NIH), as well as with 3D
reconstruction (IMARIS, Bitplane). Together, these interaction
and immunocytochemical studies suggest that Slitrk5 and
TrkB receptors interact in a BDNF-dependent manner.
BDNF Shifts Slitrk5 Binding from PTPd to TrkB
Receptors
Recently, one of the Slitrk isotypes, Slitrk3, was reported to
mediate inhibitory synapse formation through transsynaptic in-
teractions with presynaptic receptor-type protein tyrosine phos-
phatase d (PTPd) (Takahashi et al., 2012). Takahashi et al. (2012)
also showed that Slitrk5 was capable of interacting with PTPd.
Therefore, we investigated whether the BDNF-induced cis-inter-
action of Slitrk5 with TrkB disrupts the trans-interaction of Slitrk5
with PTPd (Figure 2). First, utilizing a binding assay in which we
exposed HEK293T cells expressing full-length or mutant Slitrk5
to soluble purified PTPd ectodomain fused to the Fc region of hu-
man immunoglobulin (PTPd-Fc), we showed that Slitrk5 binds
PTPd through its LRR1 domain (Figures 2A and 2B). Next, using
a heterophilic cell adhesion assay (Fogel et al., 2007), we tested
whether the presence of TrkB receptors in cells expressing
Slitrk5 affected the trans-interaction of Slitrk5 with PTPd. Briefly,
to mimic cis- and trans-interactions of Slitrk5 with TrkB and
PTPd, respectively, in the neuronal synapse, we co-cultured
HEK293 cells co-expressing FLAG-Slitrk5 and TrkB with
HEK293T cells expressing hemagglutinin (HA)-PTPd. Surface
proteins were labeled with respective antibodies at theopmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc. 691
Figure 1. TrkB Receptors Interact and Co-localize with Slitrk5
(A) Interaction between TrkB receptors and Slitrk5 was assessed in HEK293T cells overexpressing cDNAs encoding FLAG-TrkB, Slitrk5, and empty vector. Cell
lysates were immunoprecipitated with anti-FLAG antibodies and immunoblotted with anti-Slitrk5 antibodies.
(B) Interaction between TrkB receptors and Slitrk5 was assessed in HEK293-TrkB cells. Lysates fromSlitrk5-GFP or empty vector-transfectedHEK293-TrkB cells
were immunoprecipitated with anti-GFP antibodies and immunoblotted with anti-TrkB antibody.
(C) Endogenous association of Slitrk5 and TrkB. Mouse whole-brain lysates (2 months old) were subjected to immunoprecipitation with anti-TrkB antibody
(Millipore) or control IgG. The immune protein complex was then eluted, and TrkB and Slitrk5 were detected by immunoblotting.
(D and E) Interaction between TrkB and Slitrk5 is specific. (D) Interaction between TrkB and Slitrk family members. FLAG-tagged Slitrk family isotypes were
expressed in HEK293-TrkB cells. Cell lysates were immunoprecipitated with anti-TrkB antibodies (Millipore) and immunoblotted with anti-FLAG (M2) antibodies.
(E) Dissociated embryonic day 16 (E16) mouse cortical neurons were electroporated (Amaxa) with FLAG-TrkB or FLAG-TrkC. At DIV6, cell lysates were
precipitated with anti-FLAG (M2) antibodies and immunoblotted with anti-Slitrk5 antibodies.
(F) First LRR domain of Slitrk5 mediates TrkB binding. HEK293-TrkB cells were transfected with FLAG-tagged WT Slitrk5, chimeric FLAG-LRR1-domain-
swapped Slitrk5 (FLAG-LRR1(S1) Slitrk5), and LRR2-domain-swapped Slitrk5 [FLAG-LRR2(S1) Slitrk5] or empty vector. Cell lysates were precipitated with anti-
FLAG (M2) antibodies and immunoblotted with anti-TrkB antibodies (Millipore). Schematic representation of chimeric Slitrk5 mutants shown on the right.
(G) LRR domain of TrkB mediates Slitrk5 binding. Dissociated E16 mouse cortical neurons were transfected with FLAG-tagged WT TrkB, LRR domain-swapped
TrkB (FLAG-LRR(C) TrkB), and IgG1 domain-swapped TrkB [FLAG-IgG1(C) TrkB] or empty vector. At DIV6, cell lysates were immunoprecipitated with anti-FLAG
antibodies and immunoblotted with anti-Slitrk5. Schematic representation of chimeric TrkB mutants shown on the right.
(H) BDNF-dependent and TrkB kinase activity-dependent binding of TrkB and Slitrk5. After transfection of FLAG-tagged Slitrk5 into HEK293-TrkB cells, cells
were pretreated with DMSO or K252a for 30 min to inhibit kinase activity of TrkB after overnight serum starvation. Cells were treated with or without BDNF, and
their binding was examined by immunoprecipitation with anti-TrkB antibodies followed by immunoblotting with anti-FLAG antibodies.
(I) TrkB receptors co-localize with Slitrk5 in a BDNF-dependent manner. DIV6 striatal neurons were treated with or without BDNF (25 ng/ml) for 30 min after
incubating with anti-TrkB antibody to specifically label surface TrkB. Endogenous Slitrk5 and MAP2 were visualized with specific antibodies after fixation and
permeabilization. Super-resolution images were acquired using a Nikon N-SIM structured illumination microscope. The co-localization of TrkB and Slitrk5 was
presented using co-localization highlighter (ImageJ) and 3D reconstruction (IMARIS) to show more convincing co-localization signals.
(J) Histogram showing mean Manders’ coefficients for co-localization of TrkB and Slitrk5 (n = 20 for each condition). High Manders’ coefficients indicate better
co-localization of TrkB with Slitrk5. Results are means ± SEM from three independent experiments. 20–30 neurons were analyzed per condition per experiment.
*p < 0.05 significantly different from control condition (Student’s t test).
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Figure 2. PTPd and TrkB Compete for Bind-
ing to Slitrk5
(A) Slitrk5 binds PTPd through LRR1. Soluble pu-
rified PTPd-Fc chimeras were added to HEK293T
cells expressing WT and indicated deletion mu-
tants of Slitrk5, and the binding was analyzed by
immunofluorescence microscopy. Note that the
observed binding to WT Slitrk5 is abolished by
deletion of Slitrk5’s extracellular domain (ECD) or
LRR1, but not LRR2.
(B) Quantitative analysis of these results. Results
are means ± SEM from three independent
experiments. 20–30 cells were analyzed per con-
dition per experiment. ***p < 0.0001 significantly
different from WT condition (one-way ANOVA and
Dunnett’s multiple comparisons test).
(C) BDNF displaces Slitrk5 binding from PTPd to
TrkB. Heterophilic cell adhesion assay in which
HEK293-TrkB cells expressing FLAG-Slitrk5 are
co-cultured with HEK293T cells expressing HA-
PTPd. Surface proteins were visualized by fluo-
rescence microscopy in the presence or absence
of BDNF treatment (as described in Supplemental
Experimental Procedures).
(D) Fluorescence intensity trace of FLAG-Slitrk5
(green), HA-PTPd (red), and TrkB (blue) scanning
across corresponding purple arrow as indicated
in (C).
(E) Quantitative colocalization analysis of FLAG-
Slitrk5-HA-PTPd and FLAG-Slitrk5-TrkB in the
presence or absence of BDNF treatment in (C).
Results are means ± SEM from three independent
experiments. 10–15 cells showing heterophilic
adhesion were analyzed per condition per exper-
iment. ***p < 0.0001 significantly different from
control condition (two-way ANOVA and Sidak’s
multiple comparisons test).
(F) BDNF-induced dissociation of pre-bound
PTPd-Fc from HA-Slitrk5-expressing HEK293-
TrkB cells. HA-Slitrk5-expressing HEK293-TrkB
cells were pre-incubated with saturating condition
of PTPd-Fc (400 nM) for 1 hr. After washing, cells
were incubated with indicated dose of BDNF for
30 min. Remaining PTPd-Fc binding was analyzed
by immunofluorescence microscopy. Results are
means ± SEM from three independent experi-
ments. 20–30 cells were analyzed per condition
per experiment.beginning of the experiments, and their localization was
analyzed by fluorescence microscopy for cis- and trans-interac-
tions in the presence or absence of BDNF treatment. In the
absence of BDNF, all FLAG-Slitrk5 was recruited to regions of
heterophilic interaction with HA-PTPd, where the interacting pro-
teins formed stretched zipper-like structures, with minimal co-
localization with TrkB (Figures 2C–2E). In contrast, upon addition
of BDNF, FLAG-Slitrk5 co-localized with TrkB in punctate endo-
somal structures. Quantification of their co-localization showed
that the binding preference of FLAG-Slitrk5 shifted from PTPd
to TrkB upon BDNF stimulation (Figures 2D and 2E). To further
support this notion of a ligand-dependent shift in interactions,
we employed additional quantitative approaches. We examined
PTPd-Fc binding to Slitrk5 with increasing amounts of PTPd-Fc
in the presence or absence of BDNF (25 ng/ml). Results indicate
that the maximal binding capacity (Bmax) of PTPd-Fc, but notDeveldissociation constant (KD), was decreased in the presence of
BDNF (Figure S2A). This result indicates that available PTPd-Fc
binding sites were reduced by BDNF treatment without changing
affinity of PTPd-Fc to Slitrk5. The apparent KD value of PTPd-Fc
binding to Slitrk5 was 100 nM regardless of BDNF treatment.
Next, we measured dissociation of pre-bound PTPd-Fc to sur-
face-expressed HA-Slitrk5 with increasing BDNF concentra-
tions. In accordance with previous competition data (Figures
2C–2E), BDNF potently induced dissociation of pre-bound
PTPd-Fc from HA-Slitrk5-expressing HEK293-TrkB cells (Fig-
ures 2F and S2B). Based on the PTPd-Fc dissociation curve,
the KD value of BDNF to HA-Slitrk5 was 0.9 nM. These results
suggest that both PTPd and TrkB compete for binding to Slitrk5
and that, whereas under basal conditions the interaction with
PTPd predominates, BDNF stimulation directs Slitrk5 to cis-
interactions with TrkB receptors.opmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc. 693
Figure 3. Altered TrkB Receptor Activation
and Signaling in the Striatum of Slitrk5–/–
Mice
(A) Representative blots showing effect of loss of
Slitrk5 on TrkB receptor activation and its down-
stream signaling. Striatal lysates from WT and
Slitrk5/ mice (3 months old, n = 5 for each ge-
notype) were used for immunoblot analysis for
phospho-TrkB, phospho-Akt, and phospho-Erk,
with respective loading controls.
(B) Densitometric quantification of the results
shown on the right. Results are means ± SEM from
three independent experiments.
(C and D) Effects of BDNF on the growth ofWT and
Slitrk5/ striatal neurons. Cultured striatal neu-
rons from WT and Slitrk5/ mice were treated
with or without BDNF (40 ng/ml) at DIV2. After
5 days of exposure to BDNF, the cultures were
fixed and stained with anti-GAD65/67 antibody.
Neuronal processes were counted with fluores-
cent microscopy. Representative images of
BDNF-treated WT and Slitrk5/ striatal neuron
were shown in (C). Quantitation of the number of
primary and secondary dendrites in WT and
Slitrk5/ is shown in (D). Results are presented as
means ± SEM from three independent experi-
ments determined from analysis of 40 neurons per
condition per experiment (***p < 0.0001, Student’s
t test).TrkB Receptor Signaling Is Impaired in the Striatum of
Slitrk5–/– Mice
Next, we investigated whether Slitrk5 affects BDNF-mediated
TrkB signaling. First, we examined the impact of Slitrk5 on
steady-state BDNF-TrkB signaling in vivo. Western blot analyses
of striatal lysates obtained from adult WT and Slitrk5/ mice
showed that TrkB receptor activation was significantly reduced
in Slitrk5/ mice relative to WT mice (Figures 3A and 3B). This
effect on TrkB receptor activation was also reflected in a reduc-
tion in the activation of its downstream targets, Akt and extracel-
lular signal-regulated kinase (ERK)/mitogen-activated protein694 Developmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc.kinase (MAPK), in the striatum of
Slitrk5/ mice (Figures 3A and 3B).
Control experiments showed that the
reduction in TrkB receptor activation
and downstream signaling in Slitrk5/
mice was not due to alterations in BDNF
protein levels in the striatum (Figure S2A).
Second, we carried out experiments
with cultured striatal neurons to deter-
mine whether the decreased steady-
state levels of TrkB signaling in the stria-
tum of Slitrk5/ mice might be linked
to altered biological responsiveness to
BDNF. A previous study has demon-
strated that prolonged BDNF treatment
(5 days) of cultured striatal neurons
leads to a significant increase in the
number and length of dendrites (Raus-
kolb et al., 2010). After prolonged (5-
day) exposure to BDNF (40 ng/ml), WTstriatal neurons displayed 4.82 ± 0.19 primary dendrites and
8.62 ± 0.48 secondary dendrites, a 2-fold increase compared
with untreated neurons. In contrast, after 5 days of BDNF
exposure, Slitrk5/ neurons developed only 2.91 ± 0.14
primary dendrites and 4.5 ± 0.24 secondary dendrites on
average, which was not significantly different from untreated
neurons (Figures 3C and 3D). These in vitro findings indicate
that the absence of Slitrk5 causes no impairment in BDNF-in-
dependent morphogenesis of striatal neurons, but nearly abro-
gates their response to chronic BDNF. Taken together, these
in vivo and in vitro results demonstrate that Slitrk5 is necessary
for optimal long-term BDNF-dependent TrkB signaling in stria-
tal neurons.
Slitrk5 Plays a Pivotal Role in the Endocytic Recycling of
TrkB Receptors
To obtain additional insight into the mechanisms underlying the
role of Slitrk5 in BDNF-mediated TrkB signaling, we conducted
a series of biochemical and fluorescence-based immunocyto-
chemical assays. Initially, we investigated whether Slitrk5 acts,
like p75NTR, by enhancing Trk receptor responsiveness to its
ligand. To this end, we tested inWT versus Slitrk5/ striatal neu-
rons whether a low dose of BDNF (1.0 ng/ml; 15 min) can acutely
activate TrkB receptors more potently in the presence of Slitrk5.
We chose an early time point at which stageminimal TrkB recep-
tor recycling or degradation occurs (Chen et al., 2005). Our
studies demonstrated no change in short-term TrkB activation
or its downstream signaling pathways (Akt, ERK/MAPK) in
response to low-dose BDNF (Figure S4A). Next, we hypothe-
sized that the decreased steady-state TrkB signaling observed
in Slitrk5/ striatum (Figure 3A) may be due to alterations in en-
docytic TrkB receptor trafficking at a particular stage after ligand
binding. It has been established that upon binding to neurotro-
phins, Trk receptors are rapidly internalized in a clathrin-depen-
dent manner that engages endocytic adaptors (Grimes et al.,
1997; Zheng et al., 2008; Zhou et al., 2011). Trk receptor endocy-
tosis is also required for certain ligand-mediated downstream
signaling (Riccio et al., 1997; Zheng et al., 2008; Zhou et al.,
2011). To determine whether Slitrk5 functions to regulate endo-
cytosis, we utilized a fluorescent ratiometric internalization assay
we developed to study Trk receptors (Chen et al., 2005), based
on similar assays to study other signaling receptors such as
epidermal growth factor (EGF) receptors and G protein-coupled
receptors (GPCRs) (Gage et al., 2001; Tanowitz and von Zas-
trow, 2003; Vargas and Von Zastrow, 2004). Quantification of
these results confirmed that there was no significant difference
in TrkB endocytosis between WT and Slitrk5/ striatal neurons
after BDNF treatment (Figure S4B), in agreement with our obser-
vation of similar levels of BDNF-induced TrkB activation at this
time point. An alternative internalization assay using red fluores-
cent protein (RFP)-tagged BDNF confirmed that there was no
alteration in BDNF-dependent TrkB internalization in the
absence of Slitrk5 (Figures S4C and S4D).
The fate of Trk receptors after ligand binding and receptor
internalization has significant impact on the physiological re-
sponses to neurotrophins, as it determines the strength and
duration of signaling cascades initiated by activated Trk recep-
tors. One of the established postendocytic pathways of Trk re-
ceptors is their retrograde trafficking from axons to cell bodies,
which is reportedly required for trophic responses in the PNS,
but not in the CNS (Ginty and Segal, 2002; Riccio et al., 1997).
Alternatively, Trk receptors can undergo (1) trafficking to lyso-
somes, which is reflected in decreased number of surface Trk re-
ceptors and decreased responsiveness to ligand (Sommerfeld
et al., 2000); or (2) recycling to the plasma membrane, which
can lead to functional resensitization of cell-surface-specific
signaling events (Chen et al., 2005; Huang et al., 2009). The
mechanisms regulating the sorting of endocytosed Trk receptors
into these diverse pathways, a complex and highly regulated
process, remain unclear.DevelTo investigate whether interactions with Slitrk5 control the
postendocytic fates of TrkB, we examined the fate of TrkB
receptors after BDNF treatment inWT and Slitrk5/ striatal neu-
rons, using standard biotinylation experiments in which cell-sur-
face TrkB receptors are labeled and their degradation measured
after ligand treatment by immunoblot analysis (Are´valo et al.,
2006; Chen et al., 2005). In the WT striatal neurons, 30%
of TrkB was degraded within 90 min after BDNF treatment
(25 ng/ml). Interestingly, we observed increased TrkB degrada-
tion (70% in 90 min) in Slitrk5/ striatal neurons (Figures 4A
and 4B). The rate of TrkB degradation was reduced to control
levels after lentiviral transduction of WT Slitrk5 into Slitrk5/
neurons, but not after transduction of a chimeric Slitrk5 lacking
its endogenous LRR1 domain [LRR1(S1)-Slitrk5] that has been
shown not to interact with TrkB receptors.
How does the absence of Slitrk5 in cultured striatal neurons
promote accelerated ligand-dependent degradation of TrkB?
We hypothesized that Slitrk5 might promote TrkB recycling
and its absence might allow targeting of endocytosed TrkB re-
ceptors to the degradative pathway. To test this hypothesis,
we used a live-cell assay that was previously used to study recy-
cling to the plasmamembrane for TrkB and TrkA receptors (Chen
et al., 2005; Huang et al., 2009, 2013). This assay is based on the
FLAG-epitope system that allows rapid removal of fluorescei-
nated FLAG antibodies that bind to extracellular FLAG epitopes
on signaling receptors in a calcium-dependent manner (Guan
et al., 1992; Tanowitz and von Zastrow, 2003; Vargas and Von
Zastrow, 2004). InWT striatal neurons, the level of TrkB recycling
was 51% ± 1.4% (Figures 4C and 4D). In contrast, in the
Slitrk5/ striatal neurons, the level of ligand-dependent TrkB re-
cycling was significantly reduced (33% ± 0.5%). This reduction
in TrkB recycling was specifically rescued after lentiviral trans-
duction of WT Slitrk5 (56% ± 1.8%), but not after transduction
of TrkB binding-deficient Slitrk5 (39% ± 1.8%) (Figures 4C and
4D). In accordance with the binding experiments (Figures 1E
and S1E), TrkC recycling was not affected in the absence of
Slitrk5 (Figures S4E and S4F). Together, these results suggest
that Slitrk5 is required for efficient TrkB receptor recycling after
ligand treatment in striatal neurons.
Slitrk5 Facilitates TrkB Receptor Recruitment into
Rab11 Endosomes
The experiments described above indicate that the persistent
downregulation of TrkB receptors in Slitrk5/ striatal neurons
may be due to its reduced recycling rate, possibly explaining
our findings of decreased steady-state BDNF-TrkB signaling in
the striatum of Slitrk5/ mice (Figure 3A), and altered striatal
neuronal morphology (Shmelkov et al., 2010). To elucidate how
Slitrk5 regulates TrkB receptor recycling, we hypothesized that
Slitrk5 might act as a specialized sorting protein that enhances
recycling of endocytosed TrkB receptors and prevents their
incorporation into a degradative route. Recent studies have
emphasized the importance of targeting TrkB receptors to a
Rab11-positive recycling endosomes as an essential step for
the physiological function of TrkB signaling (Huang et al., 2013;
Lazo et al., 2013). Furthermore, it has been shown that TrkB
can form a complex with Rab11 that may modulate synaptic
plasticity (Huang et al., 2013) as well as BDNF-dependent den-
dritic branching (Lazo et al., 2013). To test our hypothesis, weopmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc. 695
Figure 4. Slitrk5 Plays a Pivotal Role in Ligand-Dependent TrkB Receptor Recycling
(A) Representative blot showing enhanced BDNF-induced TrkB degradation inSlitrk5/ striatal neurons.WT andSlitrk5/ striatal neuronswere transducedwith
HA-tagged WT Slitrk5, or chimeric HA-tagged-LRR1-domain-swapped (HA-LRR1(S1) Slitrk5)-expressing, or empty vector lentivirus at DIV2. Neurons were
surface biotinylated and incubated at 37C for 90 min in the absence or presence of 25 ng/ml BDNF at DIV6. Surface-labeled receptors were detected by
streptavidin pull-down followed by anti-TrkB immunoblotting.
(B) Densitometric quantification of the results from three independent experiments shown in (A) (*p < 0.05, Student’s t test).
(C and D) TrkB recycling was impaired in Slitrk5/ striatal neurons. TrkB recycling was examined in WT and Slitrk5/ neurons with live-cell fluorescence ra-
tiometric recycling assay. WT and Slitrk5/ striatal neurons were co-transfected with FLAG-tagged TrkB lentivirus, HA-tagged WT Slitrk5, or chimeric HA-
tagged-LRR1-domain-swapped (HA-LRR1(S1) Slitrk5)-expressing, or empty vector lentivirus at DIV2. Internalization of TrkB receptor was induced by BDNF
treatment for 30 min after labeling surface FLAG-tagged TrkB with Alexa 488 dye-conjugated anti-FLAG (M1) antibody. Remaining surface anti-FLAG (M1)
antibodies were removedwith EDTA-containing Ca2+/Mg2+-free PBS, and then recycling of FLAG-tagged TrkBwasmonitored in the presence of Cy3-conjugated
anti-mouse secondary antibody in culture medium. (C) Representative images from FLAG-tagged TrkB recycling experiment in striatal neurons. Control refers to
the 100% surface TrkB receptor control, and Strip refers to the 0% recycled control. The right panels of each images showed enlarged images of framed regions.
(D) Receptor recycling was quantitated as described in Experimental Procedures. Results are presented as means ± SEM from three independent experiments
determined from analysis of 30 neurons per condition per experiment (***p < 0.001, *p < 0.05, Student’s t test).initially examined whether Slitrk5 mediates recycling of TrkB
into Rab11-positive endosomes in cultured striatal neurons.
After transduction with lentivirus encoding HA-tagged Slitrk5
construct, days in vitro 6 (DIV6) WT striatal neurons were labeled
using a ‘‘live-feeding’’ method to specifically visualize cell-sur-
face HA-tagged Slitrk5 and endogenous TrkB receptors with
their respective antibodies (Chen et al., 2005; Huang et al.,
2009, 2013). Neurons were stained for Rab11 after fixation and
permeabilization. In the absence of BDNF treatment, only mini-
mal co-localization of TrkB, HA-tagged Slitrk5, and Rab11 was
detected in WT striatal neurons. In contrast, after 30 min of
BDNF treatment, there was a significant overlap of Slitrk5 and696 Developmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier ITrkB in Rab11-positive compartments (Figure 5A). This result
suggests that Slitrk5 and TrkB receptors are sorted to Rab11-
positive compartments after ligand treatment. We next investi-
gated whether Slitrk5 is required for TrkB localization to the
Rab11-positive compartments. In WT striatal neurons, there
was 3-fold increase in TrkB co-localization with Rab11 at
30 min after BDNF treatment (Figures 5B and 5C). This colocal-
ization was significantly reduced after similar treatment of BDNF
inSlitrk5/ striatal neurons (Figures 5B and 5C). Together, these
results suggest that Slitrk5 plays an important role in TrkB
recycling by facilitating TrkB sorting into Rab11-positive com-
partments after BDNF treatment.nc.
Figure 5. Slitrk5 Facilitates TrkB Receptor Recruitment into Rab11-Positive Compartments
(A) Representative images showing co-localization of TrkB receptors and Slitrk5 in Rab11-positive compartments. WT striatal neurons were transduced with HA-
tagged Slitrk5 lentivirus at DIV2. Live neurons were incubated with anti-TrkB and anti-HA antibody to specifically label cell-surface proteins and then stimulated
with or without BDNF for 30 min at DIV6. Rab11 was stained after fixation and permeabilization. Super-resolution images were acquired using a Nikon N-SIM
structured illumination microscope.
(B) Representative images showing requirement of Slitrk5 for TrkB localization into Rab11-positive compartments after BDNF treatment. Co-localization of TrkB
receptors and Rab11 was examined with WT and Slitrk5/ striatal neurons in the presence or absence of BDNF. Lower panels show enlarged images of
numbered regions in upper panels.
(C) Co-localization of TrkB and Rab11 was quantitated as described in Experimental Procedures. Results are presented asmeans ± SEM from three independent
experiments determined from analysis of nR 30 neurons per condition per experiment (***p < 0.001, Student’s t test).Slitrk5 Facilitates Rab11-FIP3 Recruitment of TrkB
Receptors to Rab11 Compartments
To obtain additional mechanistic insight on how Slitrk5 mediates
the sorting of endocytosed TrkB to the Rab11-positive compart-
ments, we screened for TrkB interacting proteins using a yeast
two-hybrid assay. An 85-amino-acid (aa) intracellular juxtamem-
brane region of the TrkB receptor was selected as bait, since the
region was shown to be important for endocytic TrkB recycling
(Chen et al., 2005; Huang et al., 2009). Among the positive clones
was Rab11-FIP3, a protein that has been also established to
interact with ADP-ribosylation factors (ARF5, ARF6) as well as
with motor proteins (kinesin I, dynein light intermediate chain)
(Horgan et al., 2010; Prekeris, 2003; Simon and Prekeris,
2008), and was previously shown to modulate recycling of
various cargoes (Horgan and McCaffrey, 2009; Prekeris, 2003).
We confirmed with co-immunoprecipitation studies that
Rab11-FIP3 and TrkB receptors interacted (Figure S5A). ToDeveltest whether there was a physical interaction between Slitrk5
and Rab11-FIP3, we transfected FLAG-tagged Slitrk5 and HA-
tagged Rab11-FIP3 plasmids into HEK293T cells and confirmed
their binding with co-immunoprecipitation study (Figure 6A).
Additional experiments with a panel of Rab11-FIPs demon-
strated that Slitrk5 bound selectively and directly to Rab11-
FIP3, but not to other Rab11-FIPs (Figures 6B and S6A), and
facilitated the interaction between TrkB and Rab11-FIP3 (Fig-
ure S5B). Rab11 was not required for Rab11-FIP3 binding to
Slitrk5; however, Rab11-FIP3 was essential for the recruitment
of Rab11 to Slitrk5 (Figures S6B–S6D). In parallel with this
biochemical study, we performed fluorescent microscopy
studies to assess co-localization of Slitrk5, TrkB, and Rab11-
FIP3 in cultured striatal neurons. Endogenous TrkB and trans-
fected HA-tagged Slitrk5 were visualized using the live-feeding
method with respective antibodies to specifically label cell-
surface TrkB and HA-tagged Slitrk5, and then endogenousopmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc. 697
Figure 6. Slitrk5 Interacts with Rab11-FIP3 to Facilitate TrkB Receptor Trafficking to Rab11-Positive Recycling Endosomes
(A and B) Representative blots showing specific interaction between Slitrk5 and Rab11-FIP3. (A) HEK293T cells were transfected with cDNAs encoding FLAG-
Slitrk5, and HA-Rab11-FIP3. Cell lysates were immunoprecipitated with anti-HA antibodies and immunoblotted with anti-FLAG antibodies. (B) HEK293T cells
were transfected with cDNAs encoding FLAG-Slitrk5, and either empty vector, Rab11-FIP3-GFP, FIP1C-GFP, FIP4-GFP, or FIP5-GFP. Cell lysates were
immunoprecipitated with anti-GFP antibodies and blotted with anti-FLAG antibodies.
(C) Representative image showing the co-localization of TrkB and Slitrk5 with Rab11-FIP3 with BDNF-dependent manner. WT striatal neurons expressing HA-
Slitrk5 were stimulated with or without BDNF after incubating with anti-TrkB and anti-HA antibody for surface protein labeling. Neurons were stained with anti-
Rab11-FIP3 antibody after fixation and permeabilization. Super-resolution images were acquired using a Nikon N-SIM structured illumination microscope.
(D) Representative images showing requirement of Slitrk5 for TrkB receptor localization in Rab11-FIP3 compartments. Co-localization of TrkB and Rab11-FIP3
was examined with WT and Slitrk5/ striatal neurons in the presence or absence of BDNF. Lower panels show enlarged images of numbered regions in upper
panels.
(E) Co-localization of TrkB and Rab11-FIP3 was quantitated as described in Experimental Procedures. Results are presented as means ± SEM from three
independent experiments determined from analysis of nR 20 neurons per condition per experiment (*p < 0.05, ***p < 0.001, Student’s t test).Rab11-FIP3 was imaged after fixation and permeabilization. The
results showed that, indeed, TrkB and Slitrk5 were co-localized
with Rab11-FIP3 after BDNF treatment (Figure 6C).Wewere also
able to see co-localization of TrkB, Slitrk5, Rab11-FIP3, and
Rab11 after BDNF treatment (Figure S6E). These findings
support a scenario in which Slitrk5 recruits Rab11-FIP3 to TrkB
receptors during postendocytic trafficking to properly target
TrkB receptors to the recycling pathway.
We next investigated whether Slitrk5 is required for TrkB local-
ization to the Rab11-FIP3-positive compartments. We used a
live-feeding method to specifically visualize cell-surface TrkB re-
ceptors with anti-TrkB antibodies (Chen et al., 2005; Huang et al.,
2009, 2013) and stained for Rab11-FIP3 after fixation and per-
meabilization. Results showed impaired TrkB localization in
Rab11-FIP3-positive compartments in Slitrk5/ striatal neurons
after BDNF treatment (Figures 6D and 6E). However, there was a698 Developmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Isignificant overlap of TrkB in compartments that were positive
for Rab11-FIP3 inWT striatal neurons after BDNF treatment (Fig-
ures 6D and 6E).
Slitrk5-Mediated Rab11-FIP3 Recruitment Is Required
for TrkB Recycling
To further examine whether Rab11-FIP3 is directly involved in
TrkB recycling, we performed live-cell fluorescent ratiometric re-
cycling assays with control small interfering RNA (siRNA) or
Rab11-FIP3 siRNA-transfected striatal neurons. Knockdown ef-
ficiency of siRNA targeting Rab11-FIP3 was validated with west-
ern blot and qPCR analyses (Figures S7A and S7B). Quantifica-
tion of these results by ratiometric analysis confirmed that TrkB
recycling was impaired in striatal neurons upon Rab11-FIP3
knockdown (36.95% ± 1.75%) compared to control siRNA
transfected (48.12% ± 2.48%) (Figures 7A and S7C). We alsonc.
Figure 7. Slitrk5-Mediated Rab11-FIP3 Recruitment Is Required for TrkB Recycling
(A) TrkB recycling was quantified with live-cell fluorescence ratiometric recycling assay in the control siRNA (Scrb) or Rab11-FIP3 siRNA-transfected striatal
neuron. Knockdown efficiency of siRNA targeting Rab11-FIP3 and representative images of live-cell fluorescence ratiometric recycling assay are shown in
Figures S4A–S4C. The error bars represent the SEM of three independent experiments (nR 30 cells for each condition per experiment (**p < 0.001, Student’s
t test).
(B) ERM domain of Rab11-FIP3 mediates Slitrk5 binding. HEK293T cells were co-transfected with cDNAs encoding FLAG-Slitrk5, and either empty vector, HA-
Rab11-FIP3, HA-Rab11-FIP3DRBD, or HA-Rab11-FIP3DERM. Cell lysates were immunoprecipitatedwith anti-HA antibodies and immunoblotted with anti-FLAG
antibodies. Schematic of Rab-FIP3 denoting established domains (EF Hand, ERM domain, and RBD [Rab11 binding domain]).
(C) Mapping domain in Slitrk5 that mediates association with Rab11-FIP3. (Left) Schematic representation shows a series of Slitrk5 deletion mutants that were
tested for the capacity to interact with Rab11-FIP3. HEK293T cells were co-transfected with cDNAs encoding HA-Rab11-FIP3 and either FLAG-Slitrk5 or FLAG-
Slitrk5DFIP3BD. (Right) Cell lysates were immunoprecipitated with anti-FLAG antibodies and immunoblotted with anti-HA antibodies.
(D) Rab11-FIP3 binding is required for Slitrk5 to rescue reduced recycling of TrkB in Slitrk5/ striatal neurons. WT and Slitrk5/ striatal neurons were co-
transfected at DIV2 with FLAG-tagged TrkB lentivirus, and either empty vector, HA-Slitrk5, or HA-tagged Rab11-FIP3 binding-deficient Slitrk5 (HA-Slitrk5D
FIP3BD). BDNF-induced TrkB recycling was measured with live-cell fluorescence ratiometric recycling assay at DIV6, as described in Experimental Procedures.
The error bars represent the SEM of three independent experiments (nR 30 cells for each condition per experiment (***p < 0.0001, Student’s t test).
(E) A cell-surface biotinylation assay shows that RAB11-FIP3 binding-deficient Slitrk5 is not able to rescue enhanced degradation of TrkB. WT and Slitrk5/
striatal neurons were transduced with empty vector, HA-tagged WT Slitrk5, or HA-Slitrk5DFIP3BD-expressing lentivirus at DIV2. At DIV6 neurons were surface
biotinylated and incubated in the presence or absence of BDNF (25 ng/ml; 90 min). Cell lysates were subjected to avidin pull-down, and TrkB levels were as-
sessed by immunoblotting with anti-TrkB antibodies.
(F) Densitometric quantification of the results was shown. The error bars represent the SEM of three independent experiments (*p < 0.05, Student’s t test).confirmed that TrkB recycling was impaired in striatal neurons
transfected with Rab11-FIP3DRBD or DERM mutant, presum-
ably due to the impaired Rab11 binding or Slitrk5 binding,
respectively (Figures S7D and S7E).
Rab11-FIP3 contains several conserved domains that may be
involved in protein-protein interactions. The central ezrin/radixin/
moesin (ERM) domain is known to interact with actin cytoskel-
eton while Rab11 binding domain is localized in the C terminus.DevelTo determine the Rab11-FIP3 domain responsible for binding to
Slitrk5, we constructed a series of deletion mutants and tested
their ability to interact with Slitrk5. Co-immunoprecipitation ex-
periments showed that the ERMdomain of Rab11-FIP3 is essen-
tial for the Slitrk5 binding (Figure 7B).
We next mapped the Rab11-FIP3 binding region on Slitrk5 us-
ing a series of C-terminal deletion mutants of Slitrk5. We found
that deletion of 13 amino acids in the intracellular region of Slitrk5opmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Inc. 699
abolished Rab11-FIP3 binding (Figure 7C). Next, we took advan-
tage of this Rab11-FIP3 binding-deficient mutant (Slitrk5D
FIP3BD) to determine whether Rab11-FIP3 is necessary for
ligand-dependent TrkB recycling. Using fluorescent ratiometric
recycling assays, we demonstrated that Slitrk5DFIP3BD was
not able to rescue the decreased recycling of TrkB in Slitrk5/
striatal neurons (Figure 7D) in contrast to WT Slitrk5. In accor-
dance with this result, a TrkB degradation experiment showed
that Slitrk5DFIP3BD was not able to reverse the enhanced rate
of TrkB degradation in Slitrk5/ striatal neurons (Figures 7E
and 7F). These complementary experiments highlight the impor-
tance of Rab11-FIP3 binding to Slitrk5 inmediating efficient TrkB
recycling in striatal neurons and suggest that Slitrk5 plays a
pivotal role in the Rab11-mediated TrkB recycling by facilitating
the recruitment of a Rab11 interacting protein, Rab11-FIP3, into
the TrkB receptor complex for efficient targeting to the recycling
endosomes.
DISCUSSION
LRR domain-containing proteins play pivotal roles in the regula-
tion of various neuronal functions, such as neurite outgrowth,
synapse formation, and dendritic morphogenesis. Two basic
mechanisms are employed by LRR proteins to execute such
functions. First, LRR proteins function in trans as cell-cell adhe-
sion molecules that mediate axon-dendrite adhesion (Gur et al.,
2004; Laederich et al., 2004; Lin et al., 2003; Shattuck et al.,
2007; Zhao et al., 2008). Second, LRR proteins act in cis to
regulate cell-surface receptor function (Gur et al., 2004; Laeder-
ich et al., 2004; Shattuck et al., 2007; Zhao et al., 2008). Here,
we have shown that Slitrk5, a postsynaptic plasma membrane
protein containing extracellular LRR domains, interacts under
basal conditions with the presynaptic adhesion molecule PTPd
in trans, but in the presence of BDNF, shifts to a cis-interaction
with TrkB receptor that mediates its postendocytic recycling,
leading to functional resensitization of neurotrophic signaling.
Of note, the Slitrk5 interaction with TrkB receptors represents
the first reported interaction among LRR proteins and receptor
tyrosine kinases (RTKs) that is mediated by the respective LRR
domains. This likely contributes to the high specificity of this
interaction and to the exclusion of other Slitrk and Trk family
members (Figure 1). In contrast to other LRR-containing pro-
teins, such as Lrigs, which negatively regulate epidermal growth
factor receptor (EGFR) and Met, Slitrk5 positively regulates TrkB
receptor activity. In addition, a recent study shows that another
LRR-containing protein, Linx, is required for NGF-TrkA and glial
cell line-derived neurotrophic factor (GDNF)-GDNF a1 (GFRa1)/
Ret-mediated sensory and motor axonal projections. Linx forms
physical complex with Trk receptors (TrkA and TrkC, but not
with TrkB) and Ret receptors; however, it was not determined
how Linx modulates RTK complexes in that study (Mandai
et al., 2009). Linx has a relatively short cytoplasmic domain
(134 aa) compared to Slitrk5 (271 aa), and does not have fea-
tures required for downstream signaling in the cytoplasmic
domain, e.g., a tyrosine phosphorylation site or a Src homology
2 (SH2) domain binding site, both observed in the intracellular
domain of Slitrk5. Interestingly, we found that Linx is required
for the recycling of TrkA (Figures S7F–S7H). Together with the
suggested role of Lrigs on EGFR ubiquitination and downregu-700 Developmental Cell 33, 690–702, June 22, 2015 ª2015 Elsevier Ilation (Gur et al., 2004; Laederich et al., 2004), these results sug-
gest that LRR protein-mediated regulation of trafficking fate
could be a universally employed mechanism for modulating
RTK signaling.
In addition to the originally established function of Slitrk fam-
ily members in regulating neuronal processes outgrowth (Abel-
son et al., 2005; Aruga and Mikoshiba, 2003), recent studies
have focused on Slitrks’ involvement in synapse formation. All
Slitrk family members have been shown to induce presynaptic
neuronal differentiation in a cellular co-culture system (Takaha-
shi et al., 2012). Slitrks have been shown to interact with
presynaptic receptor-type PTPd. Thus, Slitrks were only
considered to mediate a trans-interaction with a presynaptic re-
ceptor-type protein tyrosine phosphatase. Our current studies
elucidate a new aspect of Slitrk5 function in which Slitrk5 has
a cis-interaction with activated TrkB receptors on the surface
of postsynaptic sites via extracellular interactions. Intriguingly,
the cis-interactions of Slitrk5 with TrkB receptors compete
with trans-interactions with presynaptic partners PTPd, and
the competition was modulated by BDNF stimulation (Figure 2).
It will be important to study further the significance of the inter-
play between these three synaptic molecules during steady-
state and activity-dependent synaptic remodeling. It is inter-
esting to note that significant co-localization of Slitrk5 and
TrkB receptors occurs only after BDNF treatment, suggesting
that the interaction is enhanced after TrkB dimerization,
involving the two LRR domains in the TrkB dimer, leading to
optimal interaction with the LRR1 domain of Slitrk5. The inter-
action between the extracellular domains of Slitrk5 and TrkB
allows their intracellular interaction with Rab11-FIP3, which
mediates the recycling of TrkB receptors to the cell surface
via Rab11 recycling endosomes, while not trafficking the other
TrkB isoform, truncated TrkB receptor, to the same compart-
ments. Truncated TrkB receptors have been shown to act in
a dominant-negative manner, sequestering BDNF from full-
length TrkB (Eide et al., 1996). In striatal neurons, with limiting
BDNF supplies, Slitrk5 could thus act to efficiently recycle acti-
vated TrkB receptors, facilitating BDNF-dependent signaling
pathways.
In summary, the present study identifies an unanticipated role
of a cell-surface transmembrane protein in regulating TrkB re-
ceptor endocytic trafficking to recycling endosomes, leading to
facilitation of neurotrophic signaling in neurons. Engagement of
TrkB receptors with Slitrk5, as a co-receptor, represents a new
mechanism of how neurons within a particular brain region
with limiting BDNF levels can expand the strength and duration
of neurotrophic factor signaling. The striatum is the largest
component of the basal ganglia, and loss of striatal function
has been implicated in neurodegenerative disorders such as
Huntington’s disease and Parkinson’s disease. While neurotro-
phins and neurotrophin receptors have been thought of as po-
tential therapeutic targets for these disorders, there has been
limited success in these lines of investigation due to pharmaco-
kinetic and delivery issues. Slitrk5 represents a new potential
target for therapeutics for these neurodegenerative disorders
in which selective facilitation of BDNF-dependent signaling
could be achieved in a region-specific manner by enhancing
interaction of TrkB receptors with Slitrk5 in the absence of exog-
enous neurotrophic factors.nc.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
The reagents, antibodies, plasmid construct, siRNA, and primers used in this
study are available in Supplemental Experimental Procedures.
Production of Soluble PTPd-Fc Protein and Binding Assays
Based on previously described methods (Takahashi et al., 2012), PTPd-Fc
was generated using HEK293 cells transfected with the expression vectors,
and purified from culture media. For testing binding of soluble PTPd-Fc,
HEK293T or HEK293-TrkB cells on coverslips were transfected with the
expression vectors for WT and deletion mutants of HA-tagged Slitrk5 and
grown for 24 hr. The transfected cells were washed with extracellular solu-
tion (ECS; 168 NaCl mM, 2.4 KCl mM, 20 mM HEPES [pH 7.4], 10 mM
D-glucose, 2 mM CaCl2, 1.3 mM MgCl2) that contained 100 mg/ml BSA
(ECS/BSA) and then incubated with ECS/BSA that contained 100 nM puri-
fied PTPd Fc-fusion protein for 1 hr at room temperature in the presence or
absence of BDNF. The cells were washed in ECS, fixed with 4% paraformal-
dehyde, and incubated first with blocking solution and then with mouse
anti-HA antibody. Cells were incubated with subtype-specific fluorescen-
ated secondary antibodies and analyzed by fluorescence microscopy with
Alexa 488 dye-conjugated anti-human immunoglobulin G (IgG) (H+L) anti-
bodies (donkey IgG, 1:400, Jackson ImmunoResearch Laboratories) for
labeling of bound Fc proteins. For the PTPd-Fc dissociation experiment,
Slitrk5-expressing HEK293-TrkB cells were incubated with purified PTPd
Fc-fusion protein for 1 hr at room temperature. After washing with ECS,
PTPd Fc-bound cells were incubated with indicated dose of BDNF for
30 min at room temperature. For quantification, we measured the average
intensity of bound Fc protein per COS cell area, subtracted for off-cell
background.
Super-Resolution Microscopy
For super-resolution analysis, imaging was performed on Nikon’s structured
illumination microscope (N-SIM) Nikon Eclipse Ti that can bring the resolution
to 100–85 nm, equipped with an ANDOR camera. Images of Alexa fluors 488,
568, and 647 were acquired in 3D-SIM mode using 1003 Apo total internal
reflection fluorescence (TIRF) lens with 1.49 numerical aperture (NA).
For every z stack, 15 images were generated, resulting from three directions
and five phases, which were subsequently reconstructed using NIS-
Elements software with SIM plugin (Nikon) to generate super-resolution
data. In order to outline dendritic morphology, MAP2 images were acquired
using TIRF 405 laser and combined with SIM images. The background was
subtracted and maximum intensity projection-collapsed images are por-
trayed along with cropped segments represented in volume view. Each
experiment was repeated at least three times. See the Supplemental Exper-
imental Procedures for details on neuronal culture and imaging sample
preparation.
Analysis of Trk Receptor Recycling by using Fluorescence Ratio
Microscopy
To quantify the extent of TrkB recycling in individual neurons, an adapted
version of previous receptor recycling methods (Chen et al., 2005; Tanowitz
and von Zastrow, 2003; Vargas and Von Zastrow, 2004) was employed. Details
are available in Supplemental Experimental Procedures.
Statistical Analyses
Statistical analyses were performed using Prism v.5.0 software (GraphPad).
Statistical significance was considered at *p% 0.05, **p % 0.01, and ***p %
0.001 between the means of a minimum of three groups and was determined
using Student’s t test or one-way or two-way ANOVA test as indicated in the
figure legends. Results are expressed as the mean ± SD. All experiments
were done with at least three independent biological replicates.
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